background

Our History

Established in 1993 by Dr. Gregory A. Christopher, GGAC Research is a premier clinical research organization based in Norway, committed to driving healthcare advancements through innovation.

GGAC Research

GGAC Research: Where Science Meets Innovation for Better Outcomes.

Founded in 1993 by Dr. Gregory A. Christopher, GGAC Research has grown into a global leader in clinical research, renowned for its commitment to advancing healthcare and transforming lives. Established with a vision to revolutionize clinical trials and drug development, GGAC Research has consistently delivered innovative solutions that drive scientific breakthroughs and improve patient outcomes.

Our Early Years

Dr. Gregory Christopher, a visionary scientist and physician, founded GGAC Research in Norway to address the growing need for high-quality, reliable clinical research services. From the beginning, the organization focused on fostering collaboration between sponsors, researchers, and regulators to ensure the successful delivery of clinical trials across various therapeutic areas.

Advancing ALS Treatment

Since its inception, GGAC Research has been at the forefront of advancing treatments for Amyotrophic Lateral Sclerosis (ALS), a debilitating neurodegenerative disease. Our team has played a pivotal role in conducting groundbreaking clinical trials that have led to the development of innovative therapies aimed at improving the quality of life for ALS patients.

  • Collaborative Research Efforts: GGAC Research has partnered with leading pharmaceutical companies, academic institutions, and patient advocacy groups to accelerate the discovery and evaluation of ALS treatments.
  • Innovative Trial Design: Leveraging cutting-edge methodologies, we have contributed to the design and execution of trials that have significantly advanced the understanding of ALS and its progression.
  • Regulatory Milestones: Our expertise has been instrumental in achieving regulatory approvals for breakthrough therapies, providing hope to countless patients worldwide.

A Legacy of Excellence

Over three decades, GGAC Research has expanded its reach and capabilities, offering full-service CRO solutions across oncology, infectious diseases, vaccines, cell and gene therapy, and rare diseases. Guided by Dr. Christopher’s vision, we remain dedicated to driving innovation, ensuring patient safety, and delivering excellence in every project we undertake.

Today, GGAC Research stands as a testament to the power of collaboration, innovation, and a relentless pursuit of improving global healthcare.